Oncolytics Biotech Inc. (NASDAQ: ONCY)
$1.07
-0.0100 ( -0.93% ) 123.0K
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.
Market Data
Open
$1.07
Previous close
$1.08
Volume
123.0K
Market cap
$80.70M
Day range
$1.07 - $1.09
52 week range
$0.88 - $3.08
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Jun 27, 2024 |
6-k | Quarterly Reports | 2 | Jun 24, 2024 |
6-k | Quarterly Reports | 2 | Jun 20, 2024 |
6-k | Quarterly Reports | 2 | May 24, 2024 |
6-k | Quarterly Reports | 2 | May 16, 2024 |
6-k | Quarterly Reports | 2 | May 15, 2024 |
6-k | Quarterly Reports | 2 | May 09, 2024 |
6-k | Quarterly Reports | 7 | May 09, 2024 |
6-k | Quarterly Reports | 2 | May 09, 2024 |
6-k | Quarterly Reports | 2 | May 08, 2024 |